Century Therapeutics ($IPSC) Insider Trading & Smart Money Activity
Century Therapeutics, Inc. ($IPSC) has 12 insider trades and 1 13F position change on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($9.45K), net -$9.45K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 2
- Net insider $ (12 mo)
- -$9.45K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 1
- Analyst ratings on file
- 0
IPSC insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 2 · $9.45K | 0 / 0 | 1 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All IPSC insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Gregory RussottiTitle: Chief Technology and Manufacturing Officer | Sell (Open-market sale) | 2.58K sh | $5.76K | +2.2% | -2.2% | Read | ||||
| Insider | Douglas CarrSVP Finance & Operations | Sell (Open-market sale) | 1.65K sh | $3.69K | +2.2% | -2.2% | Read | ||||
| Insider | Alessandro Riva | Buy (Grant or award) | 74K sh | +2.2% | -1.8% | — | |||||
| Insider | Alessandro Riva | Buy (Grant or award) | 74K sh | +2.2% | -1.8% | — | |||||
| Insider | Daphne Quimi | Buy (Grant or award) | 74K sh | +2.2% | -1.8% | — | |||||
| Insider | Daphne Quimi | Buy (Grant or award) | 74K sh | +2.2% | -1.8% | — | |||||
| Insider | Murphy Martin Patrick | Buy (Grant or award) | 74K sh | +2.2% | -1.8% | — | |||||
| Insider | Murphy Martin Patrick | Buy (Grant or award) | 74K sh | +2.2% | -1.8% | — | |||||
| Insider | Lee Han Myung | Buy (Grant or award) | 74K sh | +2.2% | -1.8% | — | |||||
| Insider | Lee Han Myung | Buy (Grant or award) | 74K sh | +2.2% | -1.8% | — | |||||
| Insider | Kimberly Blackwell | Buy (Grant or award) | 74K sh | +2.2% | -1.8% | — | |||||
| Insider | Kimberly Blackwell | Buy (Grant or award) | 74K sh | +2.2% | -1.8% | — | |||||
| 13F | Rtw Investments | New | +8.70M sh | $21.30M | -3.4% | -1.7% | Read |
1W / 1M / 6M = how IPSC moved from the trade or filing date.
Insider trading in IPSC: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Gregory Russotti | Title: Chief Technology and Manufacturing Officer | 1 | -$5.76K | Jun 12, 2026 | |
| Douglas Carr | SVP Finance & Operations | 1 | -$3.69K | Jun 12, 2026 | |
| Alessandro Riva | 2 | — | Jun 11, 2026 | ||
| Daphne Quimi | 2 | — | Jun 11, 2026 | ||
| Murphy Martin Patrick | 2 | — | Jun 11, 2026 | ||
| Lee Han Myung | 2 | — | Jun 11, 2026 | ||
| Kimberly Blackwell | 2 | — | Jun 11, 2026 |
Institutions moving IPSC (13F)
Frequently asked questions
Are IPSC insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 2 open-market sales worth $9.45K, a net -$9.45K.
What is the latest insider trade in IPSC?
Gregory Russotti, Title: Chief Technology and Manufacturing Officer filed a sell (open-market sale) of 2.58K sh worth $5.76K on Jun 12, 2026.
Which institutions changed their IPSC positions?
Recent 13F filers moving the stock include Rtw Investments.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.